Search

everythinglearnresearchcommunity

for

Search:↓

Postmenopausal women with hair loss should get proper tests and consider treatments like minoxidil.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Iron deficiency is common in women regardless of hair loss, and treating it does not usually reverse hair loss.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Finasteride works for male hair loss only.

An ovarian tumor can cause high male hormones in postmenopausal women.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

The exact cause of frontal fibrosing alopecia is unknown, but it's not likely due to sunscreen.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Selenzin Peptide Active can effectively treat hair loss in postmenopausal women.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Frontal fibrosing alopecia and vitiligo might be linked by similar immune issues.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

A woman's high testosterone levels and related symptoms improved after ovary removal surgery.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.